IB Biology: Immune System and Disease

Understanding the immune system is fundamental to biology because it represents the complex and dynamic frontier where your body interacts with the living world. It’s not just about fighting colds; it’s a sophisticated defence network that distinguishes "self" from "non-self," maintains your health, and whose principles underpin modern medicine, from vaccination to the treatment of autoimmune disorders. Mastering this topic allows you to appreciate the elegance of biological adaptation and the real-world challenges of public health.

The Body's Primary and Secondary Defences

Your body’s defence is organised in layers, starting with immediate, general barriers and escalating to targeted, specific responses. The first line of defence consists of physical and chemical barriers designed to prevent entry. Your skin acts as a continuous, keratinised physical shield, while mucous membranes in respiratory, digestive, and reproductive tracts trap pathogens in sticky mucus. These surfaces are also fortified with chemical weapons: lysozyme in tears and saliva breaks down bacterial cell walls, gastric acid creates a highly acidic environment in the stomach, and sebum on the skin forms a protective acidic film.

When a pathogen breaches these barriers, the non-specific (innate) immune response is activated. This response is rapid but does not target specific pathogens. Key players here are phagocytic leucocytes (white blood cells), such as macrophages and neutrophils. They engulf and digest pathogens through a process called phagocytosis. This process is often triggered by inflammation, where damaged tissues release histamine, causing local blood vessels to dilate and become more permeable. This increases blood flow (causing heat and redness) and allows clotting elements and phagocytes to easily reach the site of infection, leading to swelling and pain. Another critical non-specific component is the complement system, a group of plasma proteins that can enhance phagocytosis, directly lyse pathogens by creating pores in their membranes, and attract more immune cells to the area.

The Specific Immune Response: B Lymphocytes and Humoral Immunity

If the innate response is insufficient, the specific (adaptive) immune response is mobilised. This response is highly specific, has memory, and involves lymphocytes: B cells and T cells. B lymphocytes (B cells) are responsible for humoral immunity, which defends against pathogens in bodily fluids like blood and lymph. Each B cell is genetically programmed to produce a unique membrane-bound receptor, an antibody, that fits a specific molecular shape on a pathogen, called an antigen.

When a B cell’s receptor binds to its specific antigen, the B cell is activated. This crucial step often requires assistance from a specific type of T cell (a helper T cell, discussed next). Once activated, the B cell undergoes rapid cell division by mitosis. This produces a clone of genetically identical cells in a process central to the clonal selection theory. This theory states that the antigen selects which lymphocyte will be activated to divide and form a clone. The clone differentiates into two main cell types: plasma cells and memory cells. Plasma cells are short-lived factories that secrete massive quantities of soluble versions of the specific antibody. These antibodies circulate, binding to antigens and marking pathogens for destruction by mechanisms like enhanced phagocytosis (opsonisation) or complement activation.

The Specific Immune Response: T Lymphocytes and Cell-Mediated Immunity

While B cells combat extracellular threats, T lymphocytes (T cells) are the generals of cell-mediated immunity, which deals with pathogens that have infected your own cells, such as viruses, and with cancerous cells. T cells mature in the thymus and have unique T cell receptors (TCRs) on their surface. Crucially, T cells cannot recognise free-floating antigens. They only recognise antigen fragments that have been processed and "presented" on the surface of your body’s own cells by proteins called Major Histocompatibility Complex (MHC) markers.

There are several key types of T cells. Helper T cells (T${}_H$) have CD4 receptors and bind to antigens presented on MHC Class II molecules, typically found on professional antigen-presenting cells like macrophages. When activated, T${}_H$ cells release cytokines that stimulate B cells, phagocytes, and other T cells, essentially orchestrating the entire adaptive immune response. Cytotoxic T cells (T${}_C$) have CD8 receptors. They bind to antigens presented on MHC Class I molecules, which are on the surface of nearly all nucleated body cells. If a T${}_C$ cell detects a foreign antigen (like a viral protein) on a cell’s MHC I, it releases perforin and granzymes to induce apoptosis (programmed cell death) in the infected cell, preventing the pathogen from replicating.

Immunological Memory and Vaccination Principles

The true power of the adaptive immune system lies in its memory. During the primary response (first encounter with an antigen), both memory B cells and memory T cells are created. These cells are long-lived and persist in the body. Upon a second exposure to the same antigen, these memory cells mount a secondary immune response. This response is far quicker, stronger, and more prolonged than the primary response. This is why you typically get certain diseases, like chickenpox, only once; your memory cells swiftly eliminate the pathogen before it can cause significant illness.

Vaccination is a medical application of this principle. A vaccine contains an antigen from a pathogen, which could be a weakened (attenuated) pathogen, a dead pathogen, or just isolated subunits of it (like a protein or polysaccharide). When administered, the vaccine stimulates a primary immune response without causing the disease. This leads to the production of memory cells. Later, if the actual pathogen invades, the existing memory cells enable a rapid and potent secondary response, providing active immunity. This protects both the individual and, when vaccination rates are high enough, the wider community through herd immunity, indirectly protecting those who cannot be vaccinated.

Challenges: Antibiotic Resistance and Emerging Diseases

Despite the immune system's sophistication, human activities create new challenges. Antibiotic resistance is a dire example of evolution by natural selection in real-time. Antibiotics are chemicals that kill or inhibit bacteria. In any bacterial population, genetic variation exists. When an antibiotic is used, bacteria susceptible to it die, but any with a random mutation conferring resistance survive. These resistant bacteria then reproduce, passing on the resistance gene. Misuse and overuse of antibiotics in medicine and agriculture accelerate this process, leading to the rise of superbugs like MRSA (Methicillin-resistant Staphylococcus aureus) that are difficult or impossible to treat.

Furthermore, emerging infectious diseases (EIDs), such as HIV/AIDS, Ebola, Zika, and novel influenza strains, pose constant threats. Factors contributing to their emergence include increased global travel and trade (rapid spread), human encroachment into wildlife habitats (exposure to new animal reservoirs), urbanisation (high-density living), and agricultural practices. These diseases often challenge the immune system in novel ways; for instance, HIV specifically targets and destroys helper T cells, crippling the entire adaptive immune response and leading to Acquired Immunodeficiency Syndrome (AIDS).

Common Pitfalls

1. Confusing Active and Passive Immunity: A common error is mixing up the source and duration of these immunity types. Active immunity (from infection or vaccination) involves your own immune system making memory cells and antibodies. It is slow to develop but long-lasting. Passive immunity (from maternal antibodies or an antibody injection) involves receiving antibodies made by another organism. It provides immediate but temporary protection, as no memory cells are created.

1. Misunderstanding Antibiotic Targets: Students often state that antibiotics work against viruses. Antibiotics are specifically designed to target structures or processes unique to bacteria, such as bacterial cell wall synthesis or prokaryotic ribosomes. They have no effect on viruses, which lack their own metabolism and hijack human cell machinery.

1. Oversimplifying Clonal Selection: It's easy to describe clonal selection as just "the antigen causes the cell to divide." The critical nuance is that the antigen selects which pre-existing lymphocyte (with a receptor that already fits it) will be activated to proliferate. The body does not create the specific receptor after encountering the antigen; it selects from a vast pre-existing repertoire.

1. Blurring the Roles of T Cell Types: Mixing up the functions of helper T cells and cytotoxic T cells is frequent. Remember: Helper T cells (CD4+) are the communicators that activate other cells. Cytotoxic T cells (CD8+) are the assassins that directly kill infected or abnormal body cells.

Summary

• The immune system operates in layered tiers: physical/chemical barriers, rapid but non-specific innate responses (phagocytosis, inflammation), and highly specific adaptive responses involving B and T lymphocytes.
• B cells mediate humoral immunity by producing antibodies against extracellular pathogens, while T cells mediate cell-mediated immunity, with helper T cells orchestrating the response and cytotoxic T cells destroying infected host cells.
• The clonal selection theory explains how a specific antigen selectively activates a matching lymphocyte, causing it to clone itself into effector and memory cells, which provide long-term immunological memory.
• Vaccines exploit immunological memory by safely provoking a primary response, leading to active immunity and contributing to community-wide herd immunity.
• Antibiotic resistance evolves through natural selection due to genetic variation in bacterial populations and is accelerated by drug misuse, while emerging diseases highlight the ongoing battle between pathogens and global public health defences.